Your browser doesn't support javascript.
loading
Ibrutinib inhibits BCR and NF-κB signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL.
Herman, Sarah E M; Mustafa, Rashida Z; Gyamfi, Jennifer A; Pittaluga, Stefania; Chang, Stella; Chang, Betty; Farooqui, Mohammed; Wiestner, Adrian.
  • Herman SE; Hematology Branch, National Heart, Lung and Blood Institute and.
  • Mustafa RZ; Hematology Branch, National Heart, Lung and Blood Institute and.
  • Gyamfi JA; Hematology Branch, National Heart, Lung and Blood Institute and.
  • Pittaluga S; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; and.
  • Chang S; Pharmacyclics Inc., Sunnyvale, CA.
  • Chang B; Pharmacyclics Inc., Sunnyvale, CA.
  • Farooqui M; Hematology Branch, National Heart, Lung and Blood Institute and.
  • Wiestner A; Hematology Branch, National Heart, Lung and Blood Institute and.
Blood ; 123(21): 3286-95, 2014 May 22.
Article en En | MEDLINE | ID: mdl-24659631
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Receptores de Antígenos de Linfocitos B / Leucemia Linfocítica Crónica de Células B / Transducción de Señal / FN-kappa B / Proliferación Celular Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirazoles / Pirimidinas / Receptores de Antígenos de Linfocitos B / Leucemia Linfocítica Crónica de Células B / Transducción de Señal / FN-kappa B / Proliferación Celular Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Año: 2014 Tipo del documento: Article